Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Metrion Biosciences

Metrion Biosciences?uq=UG6efJS6
2015 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of contract research services. The company offers ion channel screening, cardiac safety panel, translational assays, neurosciences Panel, assay development, automated patch clamp electrophysiology and related services.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Consulting Services (B2B)
Primary Office
  • Building B501
  • Babraham Research campus
  • Cambridge CB22 3AT
  • England

+44 01223 000000

Metrion Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Metrion Biosciences‘s full profile, request access.

Request full access to PitchBook

Metrion Biosciences Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Metrion Biosciences‘s full profile, request access.

Request full access to PitchBook

Metrion Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Andrew Southan Chief Operating Officer & Executive Director
Marc Rogers Ph.D Principal Scientist, Owner, Chief Scientific Officer & Director